Gilead Sciences Inc.

NAS : GILD
Pharmaceuticals
Foster City CA
Revenue (US$ Millions)$32,639
Total Equity (US$ Millions)$18,534
Total Assets (US$ Millions)$51,839
Sales Turnover0.63
Revenues Past$24,890
Revenue Growth (%)31.13%
Return On Equity (%)117.39%
Price To Earnings Ratio9.88
Net Income (US$ Millions)$18,108
Market Capitalization (US$ Millions)$143,892
Long Term Debt (US$ Millions)$21,195
Inventory Turnover2.4
Inventories (US$ Millions)$1,955
Earnings Per Share Growth (%)62.04%
Earnings per Share$11.91
Debt To Equity Ratio (%)1.14%
Current Liabilities (US$ Millions)$9,891
Current Assets (US$ Millions)$24,763
Cost of Goods Sold (US$ Millions)$4,006
Common Sharesout (Millions)$1,422